Hypertension: Beyond a bad control of blood pressure;Hipertensión arterial resistente, más allá de un mal control de la presión arterial Resistant

Medicina Clinica

Volumn 137, Issue 10, 2011, Pages 444-445

  Camafort, Miguel ^a   Coca, Antonio ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD PRESSURE REGULATION; EDITORIAL; HYPERTENSION;

EID: 80053367984     PISSN: 00257753     EISSN: 15788989     Source Type: Journal    
DOI: 10.1016/j.medcli.2011.04.023     Document Type: Article

References (18)

1. G. Mancia, G. De Backer, A. Dominiczak, R. Cifkova, R. Fagard, and G. Germano ESH-ESC Task Force on the Management of Arterial Hypertension. 2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension J Hypertens 25 2007 1751 1762 (Pubitemid 47356612)
2. G. Mancia, S. Laurent, E. Agabiti-Rosei, E. Ambrosioni, M. Burnier, and M.J. Caulfield European Society of Hypertension. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document J Hypertens 27 2009 2121 2158
3. D.A. Calhoun, D. Jones, S. Textor, D. Goff, T.P. Murphy, and R.D. Toto Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research Hypertension 51 2008 1403 1419
4. D.M. Lloyd-Jones, J.C. Evans, M.G. Larson, C.J. O'Donnell, E.J. Rocella, and D. Levy Differential control of systolic and diastolic blood pressure: factors associated with lack of blood pressure control in the community Hypertension 36 2000 594 599
5. E. Márquez-Contreras, A. Coca, M. de la Figuera, J.A. División, J.L. Llisterri, and J. Sobrino en nombre de los investigadores de Control-Project. Perfil de riesgo cardiovascular de los pacientes con hipertensión arterial no controlada. Estudio Control-Project Med Clin (Barc) 128 2007 86 91 (Pubitemid 46374283)
6. A. De la Sierra, J. Segura, J.R. Banegas, M. Gorostidi, J.I. de la Cruz, and P. Armario Clinical features of 8295 patients with resistant hypertension classified on the basis of ambulatory blood pressure monitoring Hypertension 57 2011 898 902
7. The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) JAMA 288 2002 2981 2997
8. H.R. Black, W.J. Elliott, G. Grandits, P. Grambsch, T. Lucente, and W.B. White Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial JAMA 289 2003 2073 2082 (Pubitemid 37430209)
9. S. Julius, S.E. Kjeldsen, M. Weber, H.R. Brunner, S. Ekman, and L. Hansson Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial Lancet 363 2004 2022 2031 (Pubitemid 38781102)
10. J. Redón, C. Campos, M.L. Narciso, J.L. Rodicio, J.M. Pascual, and L.M. Ruilope Prognostic value of ambulatory blood pressure monitoring in refractory hypertension: a prospective study Hypertension 31 1998 712 718
11. D.A. Calhoun, M.K. Nishizaka, M.A. Zaman, R.B. Thakkar, and P. Weissmann Hyperaldosteronism among black and white subjects with resistant hypertension Hypertension 40 2002 892 896 (Pubitemid 35434912)
12. J.J. Mukherjee, C.M. Khoo, A.C. Thai, S.B. Chionh, L. Pin, and K. Lee Type 2 diabetic patients with resistant hypertension should be screened for primary aldosteronism Diab Vasc Dis Res 7 2010 6 13
13. P. Armario, A. Oliveras, R. Hernández del Rey, L.M. Ruilope, and A. de la Sierra Prevalencia de lesión de órganos diana y alteraciones metabólicas en la hipertensión arterial refractaria Med Clin (Barc) 137 2011 435 439
14. A. Whaley-Connell, M.S. Johnson, and J.R. Sowers Aldosterone: role in the cardiometabolic syndrome and resistant hypertension Prog Cardiovasc Dis 52 2010 401 409
15. J.R. Sowers, A. Whaley-Connell, and M. Epstein The emerging clinical implications of the role of aldosterone in the metabolic syndrome and resistant hypertension Ann Intern Med 150 2009 776 783
16. J. Asbun, and F.J. Villarreal The pathogenesis of myocardial fibrosis in the setting of diabetic cardiomyopathy J Am Coll Cardiol 47 2006 693 700 (Pubitemid 43243087)
17. E. Pimenta, K.K. Gaddam, M.N. Pratt-Ubunama, M.K. Nishizaka, I. Aban, and S. Oparil Relation of dietary salt and aldosterone to urinary protein excretion in subjects with resistant hypertension Hypertension 51 2008 339 344 (Pubitemid 351159948)
18. K. Gaddam, C. Corros, E. Pimenta, M. Ahmed, T. Denney, and I. Aban Rapid reversal of left ventricular hypertrophy and intracardiac volume overload in patients with resistant hypertension and hyperaldosteronism: a prospective clinical study Hypertension 55 2010 1137 1142